Source: International Congress 2014 – Inflammation and obesity: implications for OSA



Rating:

Share or cite this content

Citations should be made in the following way:
J. Aron-Wisnewsky, E. Gras, A. Thomas, D. Godin-Ribuot, K. Clement, J. L. Pepin (Paris, La Tronche, Grenoble Cedex 09, France). Chronic intermittent hypoxia induces features of non alcoholic fatty liver disease (NAFLD) and modifies adipose tissue characteristics in lean mice. Eur Respir J 2014; 44: Suppl. 58, 4445

Member's Comments

No comment yet.

Related content which might interest you: The effect of chronic intermittent hypoxia on hepatic injury and mechanism in lean mice and mice with diet-induced obesity Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014 Chronic intermittent hypoxia induces liver injury in mice with diet induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016 Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 The influence of obstructive sleep apneao–induced  intermittant Hypoxia on Non Alcoholic  Fatty  liver. Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017 Brain oxidative stress induced by recurrent obstructive apneas: Old versus young rats Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions Year: 2014 CPAP treatment: effects on plasma lipids and liver function Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012 Does sleep loss play a role in adipose tissue dysfunction? Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Inflammation in obese adipose tissue Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Hypertension induced by chronic intermittent hypoxia: Effects of carvedilol in a rat model Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing Year: 2015 Chronic intermittent hypoxia reduces progressive sperm motility in a mouse model of obstructive sleep apnea Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 Effects of obstructive sleep apnoea on systemic inflammation and adipose tissue expression of CD40, MKK4 and JNK Source: International Congress 2014 – Inflammation and obesity: implications for OSA Year: 2014 Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in male and female patients with OSAS Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 Obesity and chronic intermittent hypoxia are independent risk factors for clinical decompensation in patients with cirrhosis and OSAS Source: International Congress 2014 – Inflammation and obesity: implications for OSA Year: 2014 Effects of normoxic recovery on intermittent hypoxia-induced changes of microbiome in a mouse model of OSA Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011 Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease. Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 Visceral adipose tissue as a target for therapeutic intervention: an update Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009